drugset / Trial / NCT04670653
Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Magnólia nasal gel in the treatment of moderate-severe persistent or moderate-severe intermittent allergic rhinitis.
Timeline
- Start
- 2022-08-01
- Primary completion
- 2023-07
- Completion
- 2023-10
Outcome
Outcome not reported
Stopped (Business): “Sponsor decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MAGNÓLIA NASAL GEL | Unknown | — | Intranasal |
| Comparator | Mometasone furoate | Other / unclassified | — | Intranasal |